Probiotics and colon cancer.

Department of Medical Nutrition, Karolinska Institute, Novum, S-141 86, Huddinge, Sweden.
Baillière&#x027 s Best Practice and Research in Clinical Gastroenterology (Impact Factor: 3.16). 11/2003; 17(5):849-59. DOI: 10.1016/S1521-6918(03)00056-8
Source: PubMed

ABSTRACT Although a myriad of health-promoting effects have been attributed to the probiotic lactic acid bacteria, perhaps the most interesting and controversial is that of anticancer activity, the vast majority of studies in this area dealing with protective effects against colon cancer. There is no direct experimental evidence for cancer suppression in humans as a result of the consumption of probiotic cultures in fermented or unfermented dairy products, but there is a wealth of indirect evidence, based largely on laboratory studies. Reports in the literature regarding the anticancer effects of lactic acid bacteria fall into the categories of in vitro studies, animal studies, epidemiological studies and human dietary intervention studies. Examples of these reports will be given in the current paper. The mechanisms by which probiotic bacteria may inhibit colon cancer are still poorly understood, but, several potential mechanisms are being discussed in the literature, and these will also be addressed in this review.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Intestinal microflora can contribute to colon cancer by the production of substances playing a role in carcinogenesis. Metabolites of protein fermentation in the colon, such as ammonia, H2S, indole, phenol, skatole are toxic. Lactic bacteria existing in the colon may exert an anti-carcinogenic action, but the mechanism is poorly understood. In the present study the ability of intestin|al lactobacilli to bind or metabolise phenol and p-cresolin vitro was determined.Lactobacillus strains were cultivated in MRS and in a modified MRS broth with reduced concentrations of carbon source. Phenol and p-cresol content in the media were from 2 to 10 μg/ml. In MRS medium lactobacilli could decrease the concentration of phenol and p-cresol and it was 0.2-5.8 μg/ml for phenol and 0.2-1.4 μg/ml for p-cresol. After cultivation in a modified MRS broth, the decrease was 0.5-2.0 μg/ml for phenol and 0.5-2.4 μg/ml for p-cresol. The binding capacity of bacterial cells was rather low. After incubation of non-growing bacteria the decrease of phenol concentration was 0.1-0.5 μg/ml and p-cresol 0.1-2.8 μg/ml. But the ability of growing lactobacilli to metabolise the compounds cannot be excluded. After interaction of lactobacilli with 10 μg/ml of phenol they displayed a lower genotoxicity, as evaluated by the alkaline comet assay. The phenomenon not always depended on the decrease of phenol concentration, but on the medium, the strain of bacteria and for phenol it ranged from 32 to 48%.Lactobacillus strains tested did not lower the genotoxicity of p-cresol.
    Annals of Microbiology 57(3):329-335. · 1.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the effect of live and dead probiotic cells on the non-specific immune system of tilapia Oreochromis niloticus, probiotics were introduced by feeding either in the form of live or dead cells, or supplying live cells to the rearing water in a closed recirculating system. The probiotics treatment enhanced non-specific immune parameters such as lysozyme activity, migration of neutrophils and plasma bactericidal activity, resulting in improvement of resistance to Edwardsiella tarda infection. Especially, oral administration of live cells seemed to be more effective compared with other probiotic treatments such as oral administration of dead probiotic cells and supply of live probiotic cells to the rearing water. These results indicate that probiotics treatment is promising as an alternative method to antibiotics for disease prevention in aquaculture, and the viability of probiotic bacteria is a key factor to induce more potential effect of probiotics used for fish production.
    Fisheries Science 08/2006; 72(4):755 - 766. · 0.90 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this work was to isolate novel lactobacilli probiotic strains from human feces and screen them for the presence of two valuable antitumor genes—the arginine deiminase-encoding gene arcA and l-asparaginase-encoding gene ansA—for future potential therapeutic application in cancer prevention. Feces samples were collected from Egyptian infants. Forty-two isolates were determined as Lactobacillus sp. and selected for further characterization. Only 20 isolates exhibited good tolerance to pH 1.5, 0.3 % bile salts and moderate tolerance to pancreatic enzymes in addition to antagonistic action. These isolates were screened by PCR for the presence of the arcA and ansA genes. Three strains were selected and identified to subspecies levels by amplification and sequencing of 16S rRNA genes as Lactobacillus gasseri NM112 containing the ansA gene; Lactobacillus fermentum NM212; and Lactobacillus casei NM312 containing the arcA gene, and confirmed by determining enzyme activity. We conclude that these three strains can be suggested as probiotics with potential therapeutic effect against cancer.
    Annals of Microbiology 01/2012; · 1.55 Impact Factor